| 000 | 01745 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250513223913.0 | ||
| 264 | 0 | _c20010103 | |
| 008 | 200101s 0 0 eng d | ||
| 022 | _a0804-4643 | ||
| 024 | 7 |
_a10.1530/eje.0.1430577 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVerhelst, J A | |
| 245 | 0 | 0 |
_aSlow-release lanreotide in the treatment of acromegaly: a study in 66 patients. _h[electronic resource] |
| 260 |
_bEuropean journal of endocrinology _cNov 2000 |
||
| 300 |
_a577-84 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study | ||
| 650 | 0 | 4 |
_aAcromegaly _xdrug therapy |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aDelayed-Action Preparations |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHormone Antagonists _xadministration & dosage |
| 650 | 0 | 4 |
_aHuman Growth Hormone _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInsulin-Like Growth Factor I _xanalysis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOctreotide _xadministration & dosage |
| 650 | 0 | 4 |
_aPeptides, Cyclic _xadministration & dosage |
| 650 | 0 | 4 |
_aPituitary Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aSomatostatin _xadministration & dosage |
| 700 | 1 | _aPedroncelli, A M | |
| 700 | 1 | _aAbs, R | |
| 700 | 1 | _aMontini, M | |
| 700 | 1 | _aVandeweghe, M V | |
| 700 | 1 | _aAlbani, G | |
| 700 | 1 | _aMaiter, D | |
| 700 | 1 | _aPagani, M D | |
| 700 | 1 | _aLegros, J J | |
| 700 | 1 | _aGianola, D | |
| 700 | 1 | _aBex, M | |
| 700 | 1 | _aPoppe, K | |
| 700 | 1 | _aMockel, J | |
| 700 | 1 | _aPagani, G | |
| 773 | 0 |
_tEuropean journal of endocrinology _gvol. 143 _gno. 5 _gp. 577-84 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1530/eje.0.1430577 _zAvailable from publisher's website |
| 999 |
_c11020688 _d11020688 |
||